Arenicin-1 vs Teduglutide
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Teduglutide (Teduglutide (glycyl-2 human glucagon-like peptide-2 analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Teduglutide |
|---|---|---|
| Category | Marine-Derived | Gastrointestinal |
| Full Name | Arenicin-1 | Teduglutide (glycyl-2 human glucagon-like peptide-2 analog) |
| Molecular Weight | 2079 Da | 3752 Da |
| Half-Life | n/a | approximately 2-3 hours |
| Amino Acids | 21 | 33 |
| Typical Dose | n/a | 0.05 mg/kg/day |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 300 |
| Research Status | Pre-clinical | Clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Teduglutide Benefits
- ✓mucosal-growth
- ✓absorption-support
- ✓barrier-repair
- ✓intestinal-adaptation
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Teduglutide Dosing
0.05 mg/kg once daily subcutaneous injection|chronic maintenance dosing in approved use|monitor fluid status and intestinal anatomy
Arenicin-1 Side Effects
- ⚠Arenicola marina
Teduglutide Side Effects
- ⚠abdominal pain
- ⚠fluid retention
- ⚠polyp/neoplasia monitoring needed
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Teduglutide
Teduglutide has robust clinical evidence showing improved intestinal absorption and reduced parenteral nutrition dependence in short bowel syndrome. Its mechanism, via GLP-2 receptor activation, makes it highly relevant to mucosal healing and intestinal adaptation research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.